Abstract
Clinical trials of disseminated Hodgkin's disease were carried out during the last ten years by Acute Leukemia Group B. A gradual development of intensification of therapy has taken place from unmaintained singleagent treatment to intensive multiple-agent therapy followed by long-term maintenance, with corresponding improvement of frequency and duration of remissions.
Original language | English |
---|---|
Pages (from-to) | 396-401 |
Number of pages | 6 |
Journal | Archives of Internal Medicine |
Volume | 131 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1973 |
Externally published | Yes |